Copy
View this email in your browser
The American Thrombosis and Hemostasis Network (ATHN) is pleased to announce that the results from the ATHN 4: VTE Project have been recently published in the January 2021 issue of Thrombosis ResearchThe article titled Transition of Care for Pediatric and Adult Patients with Venous Thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN), is now available.
View Publication

What is ATHN 4: VTE Project?

With the prevalence of venous thromboembolism (VTE) on the rise and with non-adherence to anticoagulation medications having dire consequences, the need for a clearly communicated, high-quality transition of care (TOC) plan is paramount. ATHN 4: VTE Project is a multicenter quality improvement (QI) project aimed at improving TOC from an inpatient to an outpatient setting for patients with VTE.

This ATHN project was developed to evaluate whether an enhanced educational program comprised of a comprehensive discharge instruction module plus a phone call one week after discharge would lead to improved patient and caregiver knowledge.

The project included pediatric and adult patients discharged from 16 ATHN affiliated treatment centers. With a goal of reinforcing the standardized, comprehensive education provided at discharge, patients received a follow-up phone call one week and/or 30 days after discharge for their initial VTE diagnosis.

What was the key finding?

When compared to patients discharged according to the standard policy of the institution, those who received the standardized, comprehensive education provided as part of the project had better knowledge of their medications as well as better disease recognition one month after discharge.

 

Thank you to the ATHN 4 principal investigators and participating centers 

ATHN would like to thank the principal investigators of ATHN 4: VTE Project, Maria DeSancho, MD, MSc and Madhvi Rajpurkar, MD, for their commitment to developing innovative methods to improve patient outcomes. We also acknowledge the 16 ATHN affiliated participating treatment centers and their patients, without whom this project would not have been possible. 

  • Children’s Hospital Los Angeles, University of Southern California, Keck School of Medicine

  • Wayne State University, Children’s Hospital of Michigan Hemostasis and Thrombosis Center

  • Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University

  • Dartmouth-Hitchcock Comprehensive Hemophilia & Thrombosis Center

  • Indiana Hemophilia and Thrombosis Center

  • Stead Family Department of Pediatrics, University of Iowa Children's Hospital, University of Iowa Carver College of Medicine

  • Montefiore Medical Center & The Albert Einstein College of Medicine

  • University of Texas Southwestern Medical Center / Children’s Medical Center of Dallas

  • Ohio State University Medical Center Hemophilia Treatment Center

  • Pediatric Hematology/Oncology of St. Joseph’s Children’s Hospital – Tampa

  • Hemophillia and Thrombosis Treatment Center, Rady Children’s Hospital San Diego, University of California San Diego School of Medicine

  • Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus

  • University of Michigan Hemophilia and Coagulation Disorders

  • Vermont Regional Hemophilia Center

  • Washington University Center in St. Louis – Adult Program

  • Weill Cornell Medical College – New York Presbyterian Hospital

To learn more visit ATHN 4: VTE Project or email support@athn.org.

Copyright © 2021 American Thrombosis and Hemostasis Network, All rights reserved.

Our mailing address is:
67 Red Rock Circle, Rochester, NY 14626

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.